Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene
We report the case of a 50-year-old male with major depressive disorder (MDD) to illustrate the challenge of finding effective antidepressant pharmacotherapy and the role that the patient’s genetic makeup may play. Recent treatment attempts before clinic admission included venlafaxine and fluoxetine...
Main Authors: | Céline K. Stäuble, Rebecca Meier, Markus L. Lampert, Thorsten Mikoteit, Martin Hatzinger, Samuel S. Allemann, Kurt E. Hersberger, Henriette E. Meyer zu Schwabedissen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.942268/full |
Similar Items
-
Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying <i>CYP2D6</i>*4 Variants: A Case Report
by: Céline K. Stäuble, et al.
Published: (2021-06-01) -
Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
by: Céline K. Stäuble, et al.
Published: (2021-07-01) -
Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept
by: Céline K. Stäuble, et al.
Published: (2021-09-01) -
Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy
by: Florine M. Wiss, et al.
Published: (2023-05-01) -
A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting
by: Céline K. Stäuble, et al.
Published: (2022-07-01)